Mesoblast Ltd: MSB Annual Financial Results and Operational Update
Mesoblast Ltd: Annual Financial Results Presentation
Mesoblast Ltd: Preliminary Final Report including Appendix 4E
Mesoblast Ltd: Mesoblast 2024 Full Year Financial Results Webcast
Mesoblast Ltd: Class Action Resolution
Mesoblast Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Mesoblast Ltd: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
Mesoblast Ltd: Confirmatory Phase 3 Back Pain Trial Actively Enrols
Mesoblast Ltd: Appendix 3Y for Philip Krause
Mesoblast Ltd: Notification regarding unquoted securities - MSB
Mesoblast Ltd: Notification of cessation of securities - MSB
Mesoblast Ltd: Change in substantial holding
Mesoblast Ltd: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
Mesoblast Ltd: Mesoblast to File BLA for Ryoncil FDA Approval Next Week
Mesoblast Ltd: Mesoblast Corporate Presentation at Investor Conference
Mesoblast Ltd: Corporate Presentation
Mesoblast Ltd: Appendix 3Y for Eric Rose
Mesoblast Ltd: Appendix 3Y for Eric Rose
Mesoblast Ltd: Change in substantial holding
Mesoblast Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
No Data
No Data